Result of AGM

Dechra Pharmaceuticals PLC
13 December 2023
 

 

Dechra Logo

 

 

Wednesday 13 December 2023

 

Dechra® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

 

 

A poll was held on each of the resolutions proposed at the Annual General Meeting (AGM) of the Company held today

(13 December 2023).  All resolutions were passed and are as follows:

 

Resolution (No. as noted on proxy form)

 

Total For (includes Discretionary)

Total Against

Total Cast (excludes Withheld)

Withheld (1)

 

No. of votes

% of vote

No. of votes

% of vote

No. of votes

% of ISC

No. of votes

Ordinary Business:








Resolution 1:

To receive the accounts, the Strategic Report, the Directors' Report and the Auditor's Report

 

34,668,215

99.59%

114,234

0.41%

34,832,449

30.58%

771,171

Resolution 2:

To approve the Directors' Remuneration Report

 

34,271,513

96.43%

1,269,735

3.57%

35,541,248

31.20%

62,372

Resolution 3:

To approve the Directors' Remuneration Policy

 

34,214,987

96.11%

1,384,440

3.89%

35,599,427

31.25%

4,193

Resolution 4:

To elect Geeta Gopalan

 

35,046,317

98.46%

549,509

1.54%

35,595,826

31.25%

7,794

Resolution 5:

To re-elect Alison Platt

33,364,271

95.14%

1,704,836

4.86%

35,069,107

30.79%

534,513

Resolution 6:

To re-elect Ian Page

 

34,750,073

97.61%

850,111

2.39%

35,600,184

31.26%

3,436

Resolution 7:

To re-elect Anthony Griffin

 

Withdrawn


Withdrawn


Withdrawn


Withdrawn

Resolution 8:

To re-elect Paul Sandland

 

35,440,108

99.55%

160,660

0.45%

35,600,768

31.26%

2,852

Resolution 9:

To re-elect Lisa Bright

 

34,477,141

96.84%

1,123,690

3.16%

35,600,831

31.26%

2,789

Resolution 10:

To re-elect Lawson Macartney

 

34,477,798

96.85%

1,123,033

3.15%

35,600,831

31.26%

2,789

Resolution 11:

To re-elect John Shipsey

34,476,316

96.85%

1,123,044

3.15%

35,599,360

31.25%

4,260

Resolution 12:

To re-appoint PricewaterhouseCoopers as external auditor of the company

 

34,995,995

98.30%

603,736

1.70%

35,599,731

31.25%

3,889

Resolution 13:

To authorise the Audit Committee to determine the remuneration of the external auditor

 

35,535,808

99.82%

65,691

0.18%

35,601,499

31.26%

2,121

Special Business:








Resolution 14:

To authorise the directors to allot shares to specific limits

 

34,107,454

95.91%

1,453,390

4.09%

35,560,844

31.22%

42,776

Resolution 15:

To disapply the pre-emption rights

 

35,431,245

99.94%

19,551

0.06%

35,450,796

31.12%

152,824

Resolution 16:

To disapply additional pre-emption rights

 

34,837,484

98.27%

613,429

1.73%

35,450,913

31.12%

152,707

Resolution 17:

To authorise the Company to purchase its own shares

 

35,005,559

98.45%

549,788

1.55%

35,555,347

31.22%

48,273

Resolution 18:

To authorise the Company to hold any general meeting (other than an AGM) on not less than 14 clear days' notice

 

33,696,131

94.66 %

1,901,511

5.34%

35,597,642

31.25%

5,978

 

Notes:

1.     A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

2.     Resolutions 1 to 14 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.

3.     Resolutions 15 to 18 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.

4.     Issued Share Capital at meeting date: 113,902,022

5.     Equiniti, Registrar to the Company, were appointed for the purpose of the Poll taken at the AGM and certify as scrutineer that the result of the Poll is correctly set out above.

 

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

For further information, please contact:

Melanie Hall

Company Secretary

Dechra Pharmaceuticals PLC

Telephone: +44 (0) 1606 814 730

Email: corporate.enquiries@dechra.com 

 

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.  For more information, please visit: www.dechra.com.

 

Trademarks

Trademarks appear throughout this document in italics.  Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings